Status:
UNKNOWN
Safety and Efficacy of Intermittent Renal Replacement Therapy Using CITRASATE in Critically-ill Patients
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Acute Kidney Injury
Chronic Kidney Infection
Eligibility:
All Genders
18+ years
Brief Summary
Renal Replacement Therapy (RRT) needs an extracorporeal circulation to conduct blood to the dialysis membrane and driving back to the patient. This extracorporeal circulation induces inevitably a risk...
Detailed Description
This is a retrospective descriptive study. The included patients will be those who had a Sustained Low Efficiency Dialysis using CITRASATE® dialysate in CHU Lapeyronie in Montpellier, France between 0...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age ≥18 years
- Patient underwent a RRT in the DAR Lapeyronie (CHU Montpellier) between the 01/01/2019 and the 31/12/2021
- Exclusion criteria:
- Patient underwent RRT without CITRASATE® protocol
- Lack of data
- Ethical limitation
Exclusion
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT05313230
Start Date
February 1 2022
End Date
June 30 2022
Last Update
April 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, Montepllier, France, 34295